FIMM Technology Centre is currently seeking for a senior researcher to act as Unit Head for the High Throughput Biomedicine Unit

The Institute for Molecular Medicine Finland (FIMM) is an international research institute focusing on human genomics and personalised medicine at the University of Helsinki. In the beginning of 2017 FIMM joined the University of Helsinki’s new life science research centre, Helsinki Institute of Life Science HiLIFE, as an operational unit. FIMM integrates molecular medicine research, technology centre and biobanking infrastructures under one roof, promoting translational research in grand challenge projects, specifically, the impact of genome information from the Finnish population in personalised health and medicine, individualised cancer medicine, and digital molecular medicine. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community.
FIMM Technology Centre is currently seeking for a senior researcher to act as Unit Head for the High Throughput Biomedicine Unit
The High Throughput Biomedicine (HTB) unit of the FIMM Technology Centre performs high throughput bioassays, cell-based drug screening and RNAi experiments. The unit supports research at the University of Helsinki and functions as a national and international infrastructure platform mainly for academic researchers. We are currently looking for a Unit Head.
The primary activities of the position include, but are not limited to:
          Networking and acquiring new projects
          Developing the unit’s strategy together with the director of the FIMM TC, unit staff, and unit’s user advisory panel
          Establishing and participating national and international collaborations
          Applying for national and international grants, grant reporting
          Responsibility of unit finances
Qualification and experience:
Qualification requirements include an MD/PhD, PhD or equivalent degree, postdoctoral training, project management, method development, and a strong publication record in the field. International mobility, such as training in high-quality institutions and universities globally will be valued as wells as a wide personal network in the research area. We expect that the Unit Head will engage in multidisciplinary research collaborations with other FIMM research groups, and with the life science community in Helsinki. Translational focus towards diagnostics and personalized medicine is valued along with the possibility of providing additional and novel contributions to existing FIMM and Meilahti campus research groups. Candidates should have a strong background in research and high throughput screening and proven experience with at least: industrial collaborations, project management and coordination, and supervision of personnel. Prior experience with drug sensitivity testing as well as industry/company experience, will be valued. The successful candidate is expected to have excellent problem solving, organizational, and analytical skills, and is able to work systematically. In addition, the candidate should be fluent in English, have good interpersonal and communication skills, and modern leadership skills.